Michael B. Rothberg
Columbia University Irving Medical Center, Wake Forest University, New York Proton Center
Papers
4
Total Citations
78
H-Index
3
About
Michael B. Rothberg is a urologic oncologist whose research focuses on optimizing surgical outcomes for patients with kidney cancer, particularly through nephron-sparing procedures. His major contributions center on understanding how different surgical techniques—such as partial nephrectomy, cryoablation, and radiofrequency ablation—affect renal parenchymal volume preservation and long-term kidney function. In a highly cited 2015 study (48 citations), Rothberg used 3D volume measurements to demonstrate that partial nephrectomy preserves more renal parenchyma than ablation techniques, providing critical guidance for treatment selection. He has also made significant contributions to the debate on positive surgical margins following robot-assisted partial nephrectomy, leading multi-institutional analyses (cumulatively over 28 citations) that clarified the long-term oncologic safety of these margins. His work has been presented at major urology meetings, including the American Urological Association, where he showed that minimizing normal parenchymal loss preserves renal function without increasing local recurrence. Rothberg’s research directly informs clinical decision-making for the hundreds of thousands of patients diagnosed with small renal masses annually, balancing cancer control with maximal kidney preservation.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4